Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 558 entries
Sorted by: Best Match Show Resources per page
Tacrolimus for the Treatment of Ulcerative Colitis.

Intestinal research

Matsuoka K, Saito E, Fujii T, Takenaka K, Kimura M, Nagahori M, Ohtsuka K, Watanabe M.
PMID: 26130996
Intest Res. 2015 Jul;13(3):219-26. doi: 10.5217/ir.2015.13.3.219. Epub 2015 Jun 09.

Tacrolimus is a calcineurin inhibitor used for the treatment of corticosteroid-refractory ulcerative colitis (UC). Two randomized controlled trials and a number of retrospective studies have assessed the therapeutic effect of tacrolimus in UC patients. These studies showed that tacrolimus...

Cite
Matsuoka K, Saito E, Fujii T, et al. Tacrolimus for the Treatment of Ulcerative Colitis. Intest Res. 2015;13(3):219-26doi: 10.5217/ir.2015.13.3.219.
Matsuoka, K., Saito, E., Fujii, T., Takenaka, K., Kimura, M., Nagahori, M., Ohtsuka, K., & Watanabe, M. (2015). Tacrolimus for the Treatment of Ulcerative Colitis. Intestinal research, 13(3), 219-26. https://doi.org/10.5217/ir.2015.13.3.219
Matsuoka, Katsuyoshi, et al. "Tacrolimus for the Treatment of Ulcerative Colitis." Intestinal research vol. 13,3 (2015): 219-26. doi: https://doi.org/10.5217/ir.2015.13.3.219
Matsuoka K, Saito E, Fujii T, Takenaka K, Kimura M, Nagahori M, Ohtsuka K, Watanabe M. Tacrolimus for the Treatment of Ulcerative Colitis. Intest Res. 2015 Jul;13(3):219-26. doi: 10.5217/ir.2015.13.3.219. Epub 2015 Jun 09. PMID: 26130996; PMCID: PMC4479736.
Copy Download .nbib Format: NLM
'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?.

Intestinal research

Atkinson NS, Reynolds DJ, Travis SP.
PMID: 26130997
Intest Res. 2015 Jul;13(3):227-32. doi: 10.5217/ir.2015.13.3.227. Epub 2015 Jun 09.

Proton pump inhibitors (PPIs) are widely used though an association with hypomagnesaemia and hypocalcaemia has only been described since 2006. Patients typically present after years of stable dosing with musculoskeletal, neurological or cardiac arrhythmic symptoms, but it is likely...

Cite
Atkinson NS, Reynolds DJ, Travis SP. 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?. Intest Res. 2015;13(3):227-32doi: 10.5217/ir.2015.13.3.227.
Atkinson, N. S., Reynolds, D. J., & Travis, S. P. (2015). 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?. Intestinal research, 13(3), 227-32. https://doi.org/10.5217/ir.2015.13.3.227
Atkinson, Nathan S S, et al. "'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?." Intestinal research vol. 13,3 (2015): 227-32. doi: https://doi.org/10.5217/ir.2015.13.3.227
Atkinson NS, Reynolds DJ, Travis SP. 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?. Intest Res. 2015 Jul;13(3):227-32. doi: 10.5217/ir.2015.13.3.227. Epub 2015 Jun 09. PMID: 26130997; PMCID: PMC4479737.
Copy Download .nbib Format: NLM
Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells.

Intestinal research

Kim HY, Kim SL, Park YR, Liu YC, Seo SY, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW.
PMID: 26130998
Intest Res. 2015 Jul;13(3):233-41. doi: 10.5217/ir.2015.13.3.233. Epub 2015 Jun 09.

BACKGROUND/AIMS: Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-κB (NF-κB) activity. Parthenolide (PT) inhibits NF-κB and exerts promising anticancer effects by...

Cite
Kim HY, Kim SL, Park YR, et al. Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells. Intest Res. 2015;13(3):233-41doi: 10.5217/ir.2015.13.3.233.
Kim, H. Y., Kim, S. L., Park, Y. R., Liu, Y. C., Seo, S. Y., Kim, S. H., Kim, I. H., Lee, S. O., Lee, S. T., & Kim, S. W. (2015). Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells. Intestinal research, 13(3), 233-41. https://doi.org/10.5217/ir.2015.13.3.233
Kim, Hyun-Young, et al. "Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells." Intestinal research vol. 13,3 (2015): 233-41. doi: https://doi.org/10.5217/ir.2015.13.3.233
Kim HY, Kim SL, Park YR, Liu YC, Seo SY, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW. Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells. Intest Res. 2015 Jul;13(3):233-41. doi: 10.5217/ir.2015.13.3.233. Epub 2015 Jun 09. PMID: 26130998; PMCID: PMC4479738.
Copy Download .nbib Format: NLM
Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy.

Intestinal research

Kim KT, Jang HJ, Lee JE, Kim MK, Yoo JJ, Lee GY, Kae SH, Lee J.
PMID: 26131005
Intest Res. 2015 Jul;13(3):287-90. doi: 10.5217/ir.2015.13.3.287. Epub 2015 Jun 09.

Familial Mediterranean fever (FMF) is an inherited autosomal recessive disorder, ethnically restricted and commonly found among populations surrounding the Mediterranean Sea. FMF is the most prevalent autoinflammatory disease; is characterized by recurrent, self-limited episodes of fever with serositis; and...

Cite
Kim KT, Jang HJ, Lee JE, et al. Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy. Intest Res. 2015;13(3):287-90doi: 10.5217/ir.2015.13.3.287.
Kim, K. T., Jang, H. J., Lee, J. E., Kim, M. K., Yoo, J. J., Lee, G. Y., Kae, S. H., & Lee, J. (2015). Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy. Intestinal research, 13(3), 287-90. https://doi.org/10.5217/ir.2015.13.3.287
Kim, Kwang Taek, et al. "Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy." Intestinal research vol. 13,3 (2015): 287-90. doi: https://doi.org/10.5217/ir.2015.13.3.287
Kim KT, Jang HJ, Lee JE, Kim MK, Yoo JJ, Lee GY, Kae SH, Lee J. Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy. Intest Res. 2015 Jul;13(3):287-90. doi: 10.5217/ir.2015.13.3.287. Epub 2015 Jun 09. PMID: 26131005; PMCID: PMC4479745.
Copy Download .nbib Format: NLM
Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries.

Intestinal research

Wei SC.
PMID: 27433143
Intest Res. 2016 Jul;14(3):218-23. doi: 10.5217/ir.2016.14.3.218. Epub 2016 Jun 27.

BACKGROUND/AIMS: The cost of caring for patients with inflammatory bowel disease (IBD) is high. Without government support, the cost burden will unavoidably rest on the patients and their family. However, the government providing full support will place a large...

Cite
Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res. 2016;14(3):218-23doi: 10.5217/ir.2016.14.3.218.
Wei, S. C. (2016). Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intestinal research, 14(3), 218-23. https://doi.org/10.5217/ir.2016.14.3.218
Wei, Shu Chen. "Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries." Intestinal research vol. 14,3 (2016): 218-23. doi: https://doi.org/10.5217/ir.2016.14.3.218
Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res. 2016 Jul;14(3):218-23. doi: 10.5217/ir.2016.14.3.218. Epub 2016 Jun 27. PMID: 27433143; PMCID: PMC4945525.
Copy Download .nbib Format: NLM
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Intestinal research

Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM.
PMID: 28670225
Intest Res. 2017 Jul;15(3):266-284. doi: 10.5217/ir.2017.15.3.266. Epub 2017 Jun 12.

Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A steering committee was established by the Taiwan Society of...

Cite
Wei SC, Chang TA, Chao TH, et al. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res. 2017;15(3):266-284doi: 10.5217/ir.2017.15.3.266.
Wei, S. C., Chang, T. A., Chao, T. H., Chen, J. S., Chou, J. W., Chou, Y. H., Chuang, C. H., Hsu, W. H., Huang, T. Y., Hsu, T. C., Lin, C. C., Lin, H. H., Lin, J. K., Lin, W. C., Ni, Y. H., Shieh, M. J., Shih, I. L., Shun, C. T., Tsang, Y. M., Wang, C. Y., Wang, H. Y., Weng, M. T., Wu, D. C., Wu, W. C., Yen, H. H., & Wong, J. M. (2017). Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intestinal research, 15(3), 266-284. https://doi.org/10.5217/ir.2017.15.3.266
Wei, Shu-Chen, et al. "Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease." Intestinal research vol. 15,3 (2017): 266-284. doi: https://doi.org/10.5217/ir.2017.15.3.266
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res. 2017 Jul;15(3):266-284. doi: 10.5217/ir.2017.15.3.266. Epub 2017 Jun 12. PMID: 28670225; PMCID: PMC5478753.
Copy Download .nbib Format: NLM
Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies.

Intestinal research

Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI.
PMID: 28670239
Intest Res. 2017 Jul;15(3):411-418. doi: 10.5217/ir.2017.15.3.411. Epub 2017 Jun 12.

BACKGROUND/AIMS: Colonoscopic polypectomy is the best diagnostic and therapeutic tool to detect and prevent colorectal neoplasms. However, previous studies have reported that 17% to 28% of colorectal polyps are missed during colonoscopy. We investigated the miss rate of neoplastic...

Cite
Kim NH, Jung YS, Jeong WS, et al. Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies. Intest Res. 2017;15(3):411-418doi: 10.5217/ir.2017.15.3.411.
Kim, N. H., Jung, Y. S., Jeong, W. S., Yang, H. J., Park, S. K., Choi, K., & Park, D. I. (2017). Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies. Intestinal research, 15(3), 411-418. https://doi.org/10.5217/ir.2017.15.3.411
Kim, Nam Hee, et al. "Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies." Intestinal research vol. 15,3 (2017): 411-418. doi: https://doi.org/10.5217/ir.2017.15.3.411
Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI. Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies. Intest Res. 2017 Jul;15(3):411-418. doi: 10.5217/ir.2017.15.3.411. Epub 2017 Jun 12. PMID: 28670239; PMCID: PMC5478767.
Copy Download .nbib Format: NLM
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Intestinal research

Mandavdhare HS, Sharma V, Prasad KK, Kumar A, Rathi M, Rana SS.
PMID: 28670240
Intest Res. 2017 Jul;15(3):419-421. doi: 10.5217/ir.2017.15.3.419. Epub 2017 Jun 12.

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class...

Cite
Mandavdhare HS, Sharma V, Prasad KK, et al. Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers. Intest Res. 2017;15(3):419-421doi: 10.5217/ir.2017.15.3.419.
Mandavdhare, H. S., Sharma, V., Prasad, K. K., Kumar, A., Rathi, M., & Rana, S. S. (2017). Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers. Intestinal research, 15(3), 419-421. https://doi.org/10.5217/ir.2017.15.3.419
Mandavdhare, Harshal Surendra, et al. "Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers." Intestinal research vol. 15,3 (2017): 419-421. doi: https://doi.org/10.5217/ir.2017.15.3.419
Mandavdhare HS, Sharma V, Prasad KK, Kumar A, Rathi M, Rana SS. Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers. Intest Res. 2017 Jul;15(3):419-421. doi: 10.5217/ir.2017.15.3.419. Epub 2017 Jun 12. PMID: 28670240; PMCID: PMC5478768.
Copy Download .nbib Format: NLM
Behçet's disease with multiple splenic abscesses in a child.

Intestinal research

Lim KI, Yang DH, Ryoo E.
PMID: 28670241
Intest Res. 2017 Jul;15(3):422-428. doi: 10.5217/ir.2017.15.3.422. Epub 2017 Jun 12.

We report the case of a 5-year-old male patient with multiple aseptic splenic abscesses associated with Behçet's disease. The patient visited Gachon University Gil Hospital with fever, abdominal pain, and acute watery and bloody diarrhea, and reported a 2-year...

Cite
Lim KI, Yang DH, Ryoo E. Behçet's disease with multiple splenic abscesses in a child. Intest Res. 2017;15(3):422-428doi: 10.5217/ir.2017.15.3.422.
Lim, K. I., Yang, D. H., & Ryoo, E. (2017). Behçet's disease with multiple splenic abscesses in a child. Intestinal research, 15(3), 422-428. https://doi.org/10.5217/ir.2017.15.3.422
Lim, Kyung In, et al. "Behçet's disease with multiple splenic abscesses in a child." Intestinal research vol. 15,3 (2017): 422-428. doi: https://doi.org/10.5217/ir.2017.15.3.422
Lim KI, Yang DH, Ryoo E. Behçet's disease with multiple splenic abscesses in a child. Intest Res. 2017 Jul;15(3):422-428. doi: 10.5217/ir.2017.15.3.422. Epub 2017 Jun 12. PMID: 28670241; PMCID: PMC5478769.
Copy Download .nbib Format: NLM
Small Bowel Metastatic Cancer Observed With Double Balloon Enteroscopy in a Patient With a Past History of Multiple Cancers.

Intestinal research

Song JY, Lee BJ, Yu ES, Na YJ, Park JJ, Kim JS, Bak YT.
PMID: 26576142
Intest Res. 2015 Oct;13(4):350-4. doi: 10.5217/ir.2015.13.4.350. Epub 2015 Oct 15.

Small bowel tumors are very rare and generally malignant. As a result of the anatomical location and nonspecific manifestations of small bowel tumors, they are very difficult to diagnose. Balloon-assisted enteroscopy is a relatively noninvasive method compared to surgical...

Cite
Song JY, Lee BJ, Yu ES, et al. Small Bowel Metastatic Cancer Observed With Double Balloon Enteroscopy in a Patient With a Past History of Multiple Cancers. Intest Res. 2015;13(4):350-4doi: 10.5217/ir.2015.13.4.350.
Song, J. Y., Lee, B. J., Yu, E. S., Na, Y. J., Park, J. J., Kim, J. S., & Bak, Y. T. (2015). Small Bowel Metastatic Cancer Observed With Double Balloon Enteroscopy in a Patient With a Past History of Multiple Cancers. Intestinal research, 13(4), 350-4. https://doi.org/10.5217/ir.2015.13.4.350
Song, Ji Young, et al. "Small Bowel Metastatic Cancer Observed With Double Balloon Enteroscopy in a Patient With a Past History of Multiple Cancers." Intestinal research vol. 13,4 (2015): 350-4. doi: https://doi.org/10.5217/ir.2015.13.4.350
Song JY, Lee BJ, Yu ES, Na YJ, Park JJ, Kim JS, Bak YT. Small Bowel Metastatic Cancer Observed With Double Balloon Enteroscopy in a Patient With a Past History of Multiple Cancers. Intest Res. 2015 Oct;13(4):350-4. doi: 10.5217/ir.2015.13.4.350. Epub 2015 Oct 15. PMID: 26576142; PMCID: PMC4641863.
Copy Download .nbib Format: NLM
Letter: Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation.

Intestinal research

Kang HW.
PMID: 26576145
Intest Res. 2015 Oct;13(4):362-3. doi: 10.5217/ir.2015.13.4.362. Epub 2015 Oct 15.

No abstract available.

Cite
Kang HW. Letter: Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation. Intest Res. 2015;13(4):362-3doi: 10.5217/ir.2015.13.4.362.
Kang, H. W. (2015). Letter: Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation. Intestinal research, 13(4), 362-3. https://doi.org/10.5217/ir.2015.13.4.362
Kang, Hyoun Woo. "Letter: Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation." Intestinal research vol. 13,4 (2015): 362-3. doi: https://doi.org/10.5217/ir.2015.13.4.362
Kang HW. Letter: Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation. Intest Res. 2015 Oct;13(4):362-3. doi: 10.5217/ir.2015.13.4.362. Epub 2015 Oct 15. PMID: 26576145; PMCID: PMC4641866.
Copy Download .nbib Format: NLM
Pharmacologic Agents for Chronic Diarrhea.

Intestinal research

Lee KJ.
PMID: 26576135
Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15.

Chronic diarrhea is usually associated with a number of non-infectious causes. When definitive treatment is unavailable, symptomatic drug therapy is indicated. Pharmacologic agents for chronic diarrhea include loperamide, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists, diosmectite, cholestyramine, probiotics, antispasmodics, rifaximin,...

Cite
Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015;13(4):306-12doi: 10.5217/ir.2015.13.4.306.
Lee, K. J. (2015). Pharmacologic Agents for Chronic Diarrhea. Intestinal research, 13(4), 306-12. https://doi.org/10.5217/ir.2015.13.4.306
Lee, Kwang Jae. "Pharmacologic Agents for Chronic Diarrhea." Intestinal research vol. 13,4 (2015): 306-12. doi: https://doi.org/10.5217/ir.2015.13.4.306
Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15. PMID: 26576135; PMCID: PMC4641856.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 558 entries